JoVE Logo

Войдите в систему

7.8 : Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.

The binding of dantrolene to the RYR1 inhibits the opening of the channel and blocks the release of calcium. However, dantrolene does not affect RYR2 receptors in cardiac or smooth muscle, so these organs remain minimally affected.

Dantrolene also treats malignant hyperthermia, a life-threatening heritable condition often triggered by general anesthetics or neuromuscular blockers. In some cases, individuals cannot sequester excess calcium via calcium transporters, while other affected patients have altered calcium-induced calcium release. A small calcium influx triggers a more significant calcium release from intracellular stores. The calcium release persists, muscle contraction continues, generating lactic acid and increasing the body temperature. Prompt treatment of patients with dantrolene helps reduce lactic acidosis and body temperature by inhibiting calcium release.

BoNT is a neurotoxin that acts on the presynaptic neuron's vesicle fusion proteins and inhibits acetylcholine release at the neuromuscular junction. They temporarily impede the function of specific muscles or nerves, interfering with neurotransmission, which helps paralyze muscles and relieve pain. BoNT has two subunits, a heavy chain of 100 kDa and a light chain of 50 kDa. The light chain is the active part of the neurotoxin. It proteolytically cleaves vesicle fusion proteins like SNAP-25 and synaptobrevin-2 and inhibits the exocytosis of acetylcholine-filled vesicles. BoNT is helpful in the treatment of cerebral palsy, multiple sclerosis, or cervical dystonia.

Теги

Directly Acting Muscle RelaxantsDantroleneBotulinum ToxinBoNTRyanodine ReceptorRYR1Calcium ChannelsMalignant HyperthermiaNeuromuscular JunctionAcetylcholine ReleaseNeurotransmissionMuscle ParalysisCerebral PalsyMultiple SclerosisCervical Dystonia

Из главы 7:

article

Now Playing

7.8 : Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Skeletal Muscle Relaxants

653 Просмотры

article

7.1 : Нервно-мышечное соединение и блокада

Skeletal Muscle Relaxants

2.8K Просмотры

article

7.2 : Классификация релаксантов скелетных мышц

Skeletal Muscle Relaxants

2.4K Просмотры

article

7.3 : Недеполяризующие (конкурентные) нервно-мышечные блокаторы: механизм действия

Skeletal Muscle Relaxants

1.5K Просмотры

article

7.4 : Недеполяризующие (конкурентные) нервно-мышечные блокаторы: фармакологические действия

Skeletal Muscle Relaxants

390 Просмотры

article

7.5 : Недеполяризующие (конкурентные) нервно-мышечные блокаторы: фармакокинетика

Skeletal Muscle Relaxants

429 Просмотры

article

7.6 : Деполяризующие блокаторы: механизм действия

Skeletal Muscle Relaxants

1.3K Просмотры

article

7.7 : Деполяризующие блокаторы: фармококинетика

Skeletal Muscle Relaxants

305 Просмотры

article

7.9 : Релаксанты скелетных мышц: побочные эффекты

Skeletal Muscle Relaxants

334 Просмотры

article

7.10 : Релаксанты скелетных мышц: терапевтическое применение

Skeletal Muscle Relaxants

463 Просмотры

article

7.11 : Спазмолитические реагенты: химическая классификация

Skeletal Muscle Relaxants

854 Просмотры

article

7.12 : Периферически и центрально действующие миорелаксанты: сравнение

Skeletal Muscle Relaxants

3.2K Просмотры

article

7.13 : Миорелаксанты центрального действия: терапевтическое применение

Skeletal Muscle Relaxants

620 Просмотры

JoVE Logo

Исследования

Образование

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены